Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids
Launched by CHONBUK NATIONAL UNIVERSITY HOSPITAL · Nov 23, 2012
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males and females 19-55 years old
- • Total Cholesterol 200\~260 mg/dl or LDL-C 110\~190 mg/dl
- • Able to give informed consent
- Exclusion Criteria:
- • Allergic or hypersensitive to any of the ingredients in the test products
- • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- • History of alcohol or substance abuse
- • Participation in any other clinical trials within past 2 months
- • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- • Pregnant or lactating women etc.
About Chonbuk National University Hospital
Chonbuk National University Hospital (CBNUH) is a leading academic medical center located in Jeonju, South Korea, dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, CBNUH is committed to enhancing patient care by investigating novel therapeutic approaches and improving treatment outcomes. The hospital's multidisciplinary team of experienced researchers and healthcare professionals collaborates closely with international partners to ensure compliance with ethical standards and regulatory guidelines, fostering an environment of scientific excellence and patient safety. Through its robust research infrastructure, CBNUH aims to contribute significantly to the global body of medical knowledge and improve the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jeonju, Jeollabuk Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials